Device
Trigeminal Nerve Stimulation (TNS)
Trigeminal Nerve Stimulation (TNS) is a medical device with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_1
2
50%
Ph not_applicable
1
25%
Ph phase_2
1
25%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
unknown2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)
Trials by Status
unknown250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_2
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
NCT05855369
recruitingnot_applicable
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
NCT06847165
unknownphase_1
TNS for Major Depressive Disorder: a Phase II Randomized Controlled Trial
NCT02105376
unknownphase_1
TNS for Treating Nicotine Craving
NCT02178852
Clinical Trials (4)
Showing 4 of 4 trials
NCT05855369Phase 2
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
NCT06847165Not Applicable
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
NCT02105376Phase 1
TNS for Major Depressive Disorder: a Phase II Randomized Controlled Trial
NCT02178852Phase 1
TNS for Treating Nicotine Craving
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4